Fungal Infections (Candida)
References
Barrie SA. Heidelberg pH capsule gastric analysis. In Pizzorno JE, Murray MT eds. Textbook of Natural Medicine, Volume 1. Seattle, Washington John Bastyr College Publications, 1992.
Bennett JE. Diagnosis and treatment of fungal infections. In: Harrison’s Online. June 2004a. Available at: http://harrisons.accessmedicine.com/. Accessed September 30, 2004.
Bennett JE. Candidiasis. In: Harrison’s Online. 2004b Sep. Available at: http://harrisons.accessmedicine.com/. Accessed September 30, 2004.
Braunwald DE, Kasper DL, et al. Harrison’s Principles of Internal Medicine. 15th ed. New York: McGraw-Hill Medical Publishing Division; 2001.
Buddington RK, Williams CH, et al. Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. Am J Clin Nutr. 1996 May;63(5):709–16.
CDC (Centers for Disease Control). Candidiasis. 2003 Dec. Available at: http://www.cdc.gov/ncidod/dbmd/diseaseinfo/candidiasis_t.htm. Accessed May 21, 2004.
Chami F, Chami N, et al. Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model. J Antimicrob Chemother. 2004 Nov;54(5):909–14.
Chami N, Bennis S, et al. Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo. Oral Microbiol Immunol. 2005 Apr;20(2):106–11.
Edwards L. The diagnosis and treatment of infectious vaginitis. Dermatol Ther. 2004 March;17(1):102.
Eggimann P, Garbino J, et al. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Inf Dis. 2003 Dec;3(12):772-85.
Elmer GW, Surawicz CM, et al. Biotherapeutic agents: A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA. 1996 Mar 20;275(11):870–6.
Guaschino S, De Seta F, et al. Efficacy of maintenance therapy with topical boric acid in comparison with oral itraconazole in the treatment of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 2001 Mar;184(4):598-602.
Hammer KA, Carson CF, et al. In vitro susceptibility of Malassezia furfur to the essential oil of Melaleuca alternifolia. J Med Vet Mycol. 1997 Sep-Oct;35(5):375–7.
Han Y, Lee JH. Berberine synergy with amphotericin B against disseminated candidiasis in mice. Biol Pharm Bull. 2005 Mar;28(3):541–4.
Hilton E, Isenberg HD, et al. Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med. 1992 Mar 1;116(5):353–7.
Howard MD, Gordon DT, et al. Dietary fructooligosaccharide, xylooligosaccharide and gum arabic have variable effects on cecal and colonic microbiota and epithelial cell proliferation in mice and rats. J Nutr. 1995 Oct;125(10):2604–9.
Hronek M, Vachtlova D, et al. [Antifungal effect in selected natural compounds and probiotics and their possible use in prophylaxis of vulvovaginitis]. Ceska Gynekol. 2005 Sep;70(5):395-9. Review.
Hudson T. Yeast vulvo vaginitis: Women’s Health Update. Townsend Letter for Doctors and Patients. 2003 Jan. Available at: http://www.findarticles.com/p/articles/mi_m0ISW/is_2003_Jan/ai_95676552. Accessed March 13, 2005.
Iwalokun BA, Ogunledun A, et al. In vitro antimicrobial properties of aqueous garlic extract against multidrug-resistant bacteria and Candida species from Nigeria. J Med Food. 2004 fall;7(3):327–33.
Jovanovic R, Congema E, et al. Antifungal agents vs. boric acid for treating chronic mycotic vulvovaginitis. J Reprod Med. 1991 Aug;36(8):593–7.
Kuipers ME, de Vries HG, et al. Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimicrob Agents Chemother. 1999 Nov;43(11):2635–41.
Lemar KM, Passa O, et al. Allyl alcohol and garlic (Allium sativum) extract produce oxidative stress in Candida albicans. Microbiology. 2005 Oct;151(Pt 10):3257–65.
Lupetti A, Danesi R, et al. Antimicrobial peptides: Therapeutic potential for the treatment of Candida infections. Expert Opin Investig Drugs. 2002 Feb;11(2):309–18. Review.
McGinnis MR, Molina TC, et al. Evaluation of the Biolog MicroStation system for yeast identification. J Med Vet Mycol. 1996 Sep-Oct;34(5):349–52.
Mitchell H. Vaginal discharge: Causes, diagnosis, and treatment. BMJ. 2004 May 29;328(7451):1206–8.
Nola I, Kostovic K, et al. Candida infections today: How big is the problem? Am J Obstet Gynecol. 2003 Nov;189(5):1297–300.
Orsi N. The antimicrobial activity of lactoferrin: Current status and perspectives. Biometals. 2004 Jun;17(3):189–96. Review.
Oyarzabal OA, Conner DE. In vitro fructooligosaccharide utilization and inhibition of Salmonella spp. by selected bacteria. Poult Sci. 1995 Sep;74(9):1418–25.
PDR. Physician’s Desk Reference. New York: Simon & Schuster; 2004.
Percival M. Intestinal health. Clin Nutr Insights. 1997;5(5):1–6.
Rushton RT et al. The future of medicine: the effect of tea tree oil extract on the growth of fungi. Lower Extremity. 1997;4(2):113–6.
Samaranayake YH, Samaranayake LP, et al. Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort. J Clin Microbiol. 2001 Sep;39(9):3296–302.
Shalev E, Battino S, et al. Ingestion of yogurt containing Lactobacillus acidophilus compared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis. Arch Fam Med. 1996 Nov-Dec; 5(10):593–6.
Sheppard D, Lampiris HW. Antifungal drugs. In: Katzung B, ed. Basic and Clinical Pharmacology, 9th ed. New York: McGraw-Hill/Lange Medical Books; 2004.
Slobodnikova L, Kost’alova D, et al. Antimicrobial activity of Mahonia aquifolium crude extract and its major isolated alkaloids. Phytother Res. 2004 Aug;18(8):674–6.
Sobel JD, Chaim W, et al. Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine. Am J Obstet Gynecol. 2003 Nov;189(5):1297-300.
Tampieri MP, Galuppi R, et al. The inhibition of Candida albicans by selected essential oils and their major components. Mycopathologia. 2005 Apr;159(3):339–45.
van der Kraan MI, Nazmi K, et al. Lactoferrampin, an antimicrobial peptide of bovine lactoferrin, exerts its candidacidal activity by a cluster of positively charged residues at the C-terminus in combination with a helix-facilitating N-terminal part. Biol Chem. 2005 Feb;386(2):137–42.
Viejo-Diaz M, Andres MT, et al. Different anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and kaliocin-1. Antimicrob Agents Chemother. 2005 Jul;49(7):2583–8.